mTOR: A Potential Therapeutic Target in Osteoarthritis?

Osteoarthritis (OA) is a chronic degenerative joint disease characterized by the progressive loss of articular cartilage, remodeling of the subchondral bone, and synovial inflammation. Mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase that controls critical cellular processes...

Descripción completa

Detalles Bibliográficos
Autores principales: Pal, Bandna, Endisha, Helal, Zhang, Yue, Kapoor, Mohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359178/
https://www.ncbi.nlm.nih.gov/pubmed/25688060
http://dx.doi.org/10.1007/s40268-015-0082-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359178/
https://www.ncbi.nlm.nih.gov/pubmed/25688060
http://dx.doi.org/10.1007/s40268-015-0082-z

Ejemplares similares